基于核酸的方法来应对KRAS突变癌症
Jimi Kim1,2
1Department of Life Sciences, Gachon University, Seongnam 13120, Republic of Korea.
International journal of molecular sciences
|December 9, 2023
概括
下一代基于核酸的疗法为KRAS突变癌症提供了新的希望,此前被认为是无法治疗的. 本综述探讨了它们的机制,挑战以及针对这些具有挑战性的瘤的临床进展.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物开发 药物开发
背景情况:
- 激活KRAS突变是许多癌症的关键驱动因素.
- 从历史上看,KRAS被认为是无法治疗的,限制了治疗选择.
- 核酸化学和输送方面的进步使新的治疗策略成为可能.
研究的目的:
- 审查针对KRAS突变癌症的进展情况.
- 概述基于核酸的治疗策略的发展情况.
- 为这些新疗法的机制,挑战和临床试验提供见解.
主要方法:
- 目前研究和临床试验的文献综述.
- 基于核酸的治疗策略的分析.
- 讨论行动机制和挑战.
主要成果:
- 基于核酸的疗法代表了KRAS抑制的范式转变.
- 在开发这些下一代药物方面取得了重大进展.
- 目前正在研究各种策略,正在进行临床试验.
结论:
- 基于核酸的策略具有治疗KRAS突变癌症的巨大潜力.
- 克服现有的挑战对于临床成功至关重要.
- 这种方法为向癌症治疗提供了一个有希望的未来.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.0K
10:13A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
11.2K
相关概念视频
02:38The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:24Small GTPases - Ras and Rho
4.0K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.0K